Century Therapeutics (IPSC) Q2 2024 Earnings Report

294 Followers

IPSC Q2 2024 EPS Results

Actual EPS-$0.38

Consensus EPS-$0.46

Beat/MissBeat by +$0.08

One Year Ago EPS-$0.56

Actual Revenue$771.00K

Expected Revenue$430.00K

Beat/MissBeat by +$341.00K

YoY Revenue Growth+678.79%

QuarterQ2 2024

Date08/08/2024

TimeBefore Open

Conference CallThursday, August 8, 2024

IPSC Upcoming Earnings

Century Therapeutics's next earnings date is estimated for November 5, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 05, 2026	2026 (Q3)	-0.12 / -	-0.4	―
Aug 12, 2026	2026 (Q2)	-0.11 / -0.17	-0.38	55.26% (+0.21)
May 13, 2026	2026 (Q1)	-0.16 / -0.11	0.89	-112.36% (-1.00)
Mar 12, 2026	2025 (Q4)	-0.29 / -0.25	-0.41	39.02% (+0.16)
Nov 13, 2025	2025 (Q3)	-0.34 / -0.40	-0.37	-8.11% (-0.03)
Aug 14, 2025	2025 (Q2)	-0.38 / -0.38	-0.38	0.00% (0.00)
May 15, 2025	2025 (Q1)	>-0.01 / 0.89	-0.45	297.78% (+1.34)
Mar 19, 2025	2024 (Q4)	-0.41 / -0.41	-0.66	37.88% (+0.25)
Nov 05, 2024	2024 (Q3)	-0.45 / -0.37	-0.55	32.73% (+0.18)
Aug 08, 2024	2024 (Q2)	-0.46 / -0.38	-0.56	32.14% (+0.18)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed